Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

Abstract

The occurrence of new CV events in very early RA was explained by traditional CV risk factors and was potentiated by high disease activity. Treatment with DMARDs decreased the risk. The results may have implications for cardio-protective strategies in RA.